The European Generic Medicines Association - Pharmaceutical Technology Magazine
Fri, 30 Jul 2010 11:44:09 GMT+00:00
Pharmaceutical Technology Magazine Consequently, the term 'biosimilar' should only be applied to biopharmaceuticals that have been approved in accordance with the EU legal basis and data ... The Changing Landscape For Biosimilars Pharmaceutical Technology Magazine Biosimilars: Is It Worth Taking On The Regulators? Pharmaceutical Technology Magazine What Is Hindering The Uptake Of Biosimilars? Pharmaceutical Technology Magazine
Fri, 30 Jul 2010 11:44:09 GMT+00:00
Pharmaceutical Technology Magazine Consequently, the term 'biosimilar' should only be applied to biopharmaceuticals that have been approved in accordance with the EU legal basis and data ... The Changing Landscape For Biosimilars Pharmaceutical Technology Magazine Biosimilars: Is It Worth Taking On The Regulators? Pharmaceutical Technology Magazine What Is Hindering The Uptake Of Biosimilars? Pharmaceutical Technology Magazine
Pacgen Reports Fiscal 2010 Financial Results - MarketWatch (press release)
Fri, 30 Jul 2010 05:07:17 GMT+00:00
MarketWatch (press release) vancouver, british columbia, Jul 30, 2010 (Marketwire via COMTEX) -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX:CA:PGA) reported ... Pacgen Reports Fiscal 2010 Financial Results istockAnalyst.com (press release)
Fri, 30 Jul 2010 05:07:17 GMT+00:00
MarketWatch (press release) vancouver, british columbia, Jul 30, 2010 (Marketwire via COMTEX) -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX:CA:PGA) reported ... Pacgen Reports Fiscal 2010 Financial Results istockAnalyst.com (press release)
Earnings Preview: Keryx Biopharmaceuticals's Quarterly Results will be ... - Comtex Smartrend
Sun, 25 Jul 2010 21:09:56 GMT+00:00
Quarterly Results will be ... Comtex Smartrend Analysts, on average, expect Keryx Biopharmaceuticals (NASDAQ:KERX) to report a loss of $0.09 on sales of $10 thousand on August 05, 2010. ...
Sun, 25 Jul 2010 21:09:56 GMT+00:00
Quarterly Results will be ... Comtex Smartrend Analysts, on average, expect Keryx Biopharmaceuticals (NASDAQ:KERX) to report a loss of $0.09 on sales of $10 thousand on August 05, 2010. ...
Nabi Biopharmaceuticals Completes Enrollment of First NicVAX Phase III ... - MarketWatch (press release)
Wed, 14 Jul 2010 13:06:50 GMT+00:00
Completes Enrollment of First NicVAX Phase III ... MarketWatch (press release) Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in ...
Wed, 14 Jul 2010 13:06:50 GMT+00:00
Completes Enrollment of First NicVAX Phase III ... MarketWatch (press release) Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in ...
Western States Biopharmaceuticals and University of Colorado Announce ... - PR Newswire (press release)
Thu, 08 Jul 2010 12:03:59 GMT+00:00
and University of Colorado Announce ... PR Newswire (press release) "The university is very pleased to memorialize a partnership with Western States Biopharmaceuticals , a company we believe is ideally positioned to bring ...
Thu, 08 Jul 2010 12:03:59 GMT+00:00
and University of Colorado Announce ... PR Newswire (press release) "The university is very pleased to memorialize a partnership with Western States Biopharmaceuticals , a company we believe is ideally positioned to bring ...
Spectrum Pharmaceuticals Names Chief Scientific Officer - socalTech.com
Mon, 19 Jul 2010 12:33:19 GMT+00:00
socalTech.com Irvine-based Spectrum Pharmaceuticals, a biopharmaceuticals firm focused on hematology and oncology, said today that it has named George Tidmarsh, MD, ... Spectrum Pharmaceuticals Appoints George Tidmarsh, M.D., Ph.D, as Senior Vice ... MarketWatch (press release) Spectrum names chief science officer BusinessWeek
Mon, 19 Jul 2010 12:33:19 GMT+00:00
socalTech.com Irvine-based Spectrum Pharmaceuticals, a biopharmaceuticals firm focused on hematology and oncology, said today that it has named George Tidmarsh, MD, ... Spectrum Pharmaceuticals Appoints George Tidmarsh, M.D., Ph.D, as Senior Vice ... MarketWatch (press release) Spectrum names chief science officer BusinessWeek
Calls Purchased on Geron Corp. (GERN) - Benzinga
Mon, 19 Jul 2010 17:53:44 GMT+00:00
Benzinga Geron Corporation is a biopharmaceutical company that is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, ... Geron Corp commences randomised Phase 2 clinical trial of imetelstat in nsclc foxbusiness Earnings Watch: Geron is Scheduled to Report its Quarterly Results in 13 days ... Comtex Smartrend
Mon, 19 Jul 2010 17:53:44 GMT+00:00
Benzinga Geron Corporation is a biopharmaceutical company that is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, ... Geron Corp commences randomised Phase 2 clinical trial of imetelstat in nsclc foxbusiness Earnings Watch: Geron is Scheduled to Report its Quarterly Results in 13 days ... Comtex Smartrend
SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters ... - PR Newswire (press release)
Thu, 29 Jul 2010 13:00:41 GMT+00:00
PR Newswire (press release) As world leaders in advancing biopharmaceuticals from bench to market, we very much look forward to helping Versartis also meet their corporate objectives ...
Thu, 29 Jul 2010 13:00:41 GMT+00:00
PR Newswire (press release) As world leaders in advancing biopharmaceuticals from bench to market, we very much look forward to helping Versartis also meet their corporate objectives ...
Theratechnologies stock drops on FDA delay - Reuters
Tue, 20 Jul 2010 14:57:01 GMT+00:00
Reuters toronto july 20 (Reuters) - Shares of Canadian biopharmaceuticals company Theratechnologies (TH.TO) fell more than 18 percent on Tuesday after US regulators ...
Tue, 20 Jul 2010 14:57:01 GMT+00:00
Reuters toronto july 20 (Reuters) - Shares of Canadian biopharmaceuticals company Theratechnologies (TH.TO) fell more than 18 percent on Tuesday after US regulators ...
Positron increases production capacity due to increased demand. After the bell ... - BioMedReports (subscription)
Fri, 09 Jul 2010 08:10:48 GMT+00:00
BioMedReports (subscription) RegeneRx Biopharmaceuticals , Inc. (NYSE Amex: RGN) today announced it has received Notice of Acceptance from the Australian patent office for the use of ...
Fri, 09 Jul 2010 08:10:48 GMT+00:00
BioMedReports (subscription) RegeneRx Biopharmaceuticals , Inc. (NYSE Amex: RGN) today announced it has received Notice of Acceptance from the Australian patent office for the use of ...
Texas lawmaker solicits questions for forum via Twitter - The Hill (blog)
Mon, 19 Jul 2010 19:35:41 GMT+00:00
The Hill (blog) The event discussed the effects of March's healthcare overhaul on biosimilars, or new versions of biopharmaceuticals whose patents have expired. ...
Mon, 19 Jul 2010 19:35:41 GMT+00:00
The Hill (blog) The event discussed the effects of March's healthcare overhaul on biosimilars, or new versions of biopharmaceuticals whose patents have expired. ...
The Global Market for Membrane Microfiltration - TMCnet
Fri, 16 Jul 2010 11:13:08 GMT+00:00
TMCnet ... biopharmaceuticals manufacture, potable water production, wastewater treatment, industrial processes, and semiconductor fabrication. ...
Fri, 16 Jul 2010 11:13:08 GMT+00:00
TMCnet ... biopharmaceuticals manufacture, potable water production, wastewater treatment, industrial processes, and semiconductor fabrication. ...
Good News/Bad News - Looks at GHII, ROVI, and KERX - Small Cap Network
Wed, 07 Jul 2010 15:32:17 GMT+00:00
Small Cap Network Small caps Keryx Biopharmaceuticals , Gold Horse International, and Rovi Corporation are reviewed for trade-worthiness. By James E. Brumley The good news is, ...
Wed, 07 Jul 2010 15:32:17 GMT+00:00
Small Cap Network Small caps Keryx Biopharmaceuticals , Gold Horse International, and Rovi Corporation are reviewed for trade-worthiness. By James E. Brumley The good news is, ...
AHGP, NABI, and ORFG.pk On PennyToBucks Watch List - CRWE NewsWire (press release)
Mon, 26 Jul 2010 15:41:17 GMT+00:00
CRWE NewsWire (press release) Nabi Biopharmaceuticals (Nasdaq:NABI) will report its second quarter 2010 financial results on Thursday, August 5, 2010, after the market close. ...
Mon, 26 Jul 2010 15:41:17 GMT+00:00
CRWE NewsWire (press release) Nabi Biopharmaceuticals (Nasdaq:NABI) will report its second quarter 2010 financial results on Thursday, August 5, 2010, after the market close. ...
Brickell Biotech, With Roche's Abercrombie on Board, Raises $6.2M - cbl - Citybizlist (press release)
Mon, 26 Jul 2010 14:47:23 GMT+00:00
Citybizlist (press release) based anti-cancer biopharmaceuticals company; Charles Betlach, a director of Concordia and Palo Alto, Calif-based development-stage biopharmaceutical ...
Mon, 26 Jul 2010 14:47:23 GMT+00:00
Citybizlist (press release) based anti-cancer biopharmaceuticals company; Charles Betlach, a director of Concordia and Palo Alto, Calif-based development-stage biopharmaceutical ...
UBC Secures Additional $150 Million From Capital Markets - MarketWatch (press release)
Tue, 06 Jul 2010 10:06:44 GMT+00:00
MarketWatch (press release) In a recent independent survey, customers in the biopharmaceutical industry ranked UBC above all other pharmaceutical service companies in the late stage ...
Tue, 06 Jul 2010 10:06:44 GMT+00:00
MarketWatch (press release) In a recent independent survey, customers in the biopharmaceutical industry ranked UBC above all other pharmaceutical service companies in the late stage ...
Health care sector high volumes: (BSX, THC, HMA, KG, ELN) - Penny Stock Live (blog)
Thu, 29 Jul 2010 12:01:04 GMT+00:00
Penny Stock Live (blog) Elan's operations are organized into two business units: BioNeurology (formerly Biopharmaceuticals ) and Elan Drug Technologies (EDT). ...
Thu, 29 Jul 2010 12:01:04 GMT+00:00
Penny Stock Live (blog) Elan's operations are organized into two business units: BioNeurology (formerly Biopharmaceuticals ) and Elan Drug Technologies (EDT). ...
Biocon net up 52% as biopharma sales surge - Hindu Business Line
Fri, 23 Jul 2010 18:45:00 GMT+00:00
Hindu Business Line Net sales grew 33 per cent to Rs 322.4 crore (Rs 242.79 crore), buoyed by 37 per cent sales growth in the core business of biopharmaceuticals . ...
Fri, 23 Jul 2010 18:45:00 GMT+00:00
Hindu Business Line Net sales grew 33 per cent to Rs 322.4 crore (Rs 242.79 crore), buoyed by 37 per cent sales growth in the core business of biopharmaceuticals . ...
Venture Investment in China Increases 43% in Second Quarter - The FINANCIAL
Thu, 29 Jul 2010 08:36:37 GMT+00:00
The financial as usual, the Biopharmaceuticals sector took the lion's share (52%) of investment, attracting $65 million for three deals. "Consumer Services has long been ...
Thu, 29 Jul 2010 08:36:37 GMT+00:00
The financial as usual, the Biopharmaceuticals sector took the lion's share (52%) of investment, attracting $65 million for three deals. "Consumer Services has long been ...
Canada Hot Stocks: Sprott Inc., ISE Ltd., West 49 - Wall Street Journal
Wed, 14 Jul 2010 15:09:45 GMT+00:00
Wall Street Journal AEterna's ($1.18, $0.09, 8.3%) US partner, Keryx Biopharmaceuticals Inc. (KERX), has been granted orphan-drug designation for perifosine, a treatment for ...
Wed, 14 Jul 2010 15:09:45 GMT+00:00
Wall Street Journal AEterna's ($1.18, $0.09, 8.3%) US partner, Keryx Biopharmaceuticals Inc. (KERX), has been granted orphan-drug designation for perifosine, a treatment for ...
From Google News Search: 'biopharmaceuticals'
Sat Jul 31 07:31:43 2010 [ refresh local cache ]
[Hide]▼
THAPAR UNIVERSITY Conference on Emerging Trends in ...
admin
Mon, 21 Jun 2010 10:12:31 GM
helpBIOTECH Happy to Announce: Department of Biotechnology & Environmental Sciences TIFAC-Core thapar university patiala 147004 Punjab National Conference on Emerging Trends in . Biopharmaceuticals. : Relevance to Human Health November ...
admin
Mon, 21 Jun 2010 10:12:31 GM
helpBIOTECH Happy to Announce: Department of Biotechnology & Environmental Sciences TIFAC-Core thapar university patiala 147004 Punjab National Conference on Emerging Trends in . Biopharmaceuticals. : Relevance to Human Health November ...
I am starting a Nutritional Company: Which name sounds good for it?
Q. I want something that represents western medication + eastern medication: Here are some Ideas: 1. Om BioPharmaceuticals 2. Om BioPharma 3. Om AyurPharma 4. Om Naturapharm What do you guys think? Any other ideas?
Asked by husctla - Thu Apr 16 16:20:32 2009 - - 1 Answers - 0 Comments
A. out of those choices, Om Naturapharm sounds best.
Answered by Emily Hayward - Thu Apr 16 16:31:28 2009
Q. I want something that represents western medication + eastern medication: Here are some Ideas: 1. Om BioPharmaceuticals 2. Om BioPharma 3. Om AyurPharma 4. Om Naturapharm What do you guys think? Any other ideas?
Asked by husctla - Thu Apr 16 16:20:32 2009 - - 1 Answers - 0 Comments
A. out of those choices, Om Naturapharm sounds best.
Answered by Emily Hayward - Thu Apr 16 16:31:28 2009
[Hide]▲

















